Market Place
Sourcing Support
Fog clears to reveal Parabilis, a rebranded cancer biotech
28 Oct 2024 //
FIERCE PHARMA
Parabilis Medicines™ Unveils New Name and Discovery Platform
28 Oct 2024 //
BUSINESSWIRE
FogPharma, ARTBIO Collaborate On Helicon Alpha-Particle Radioligand Therapies
14 May 2024 //
BUSINESSWIRE
FogPharma, ARTBIO Partner to Develop Helicon-Enabled ARTs (HEARTs)
14 May 2024 //
BUSINESSWIRE
FogPharma Announces $145 Million Financing
01 Mar 2024 //
BUSINESSWIRE
FogPharma clears $145M series E thanks to Borisy, ex-J&J CEO
01 Mar 2024 //
FIERCE BIOTECH
FogPharma to Present at the 42nd Annual J.P. Morgan Healthcare Conference
04 Jan 2024 //
BUSINESSWIRE
FogPharma Announces First Patient Dosed in Phase 1/2 Clinical Trial of FOG-001
05 Jun 2023 //
BUSINESSWIRE
Mathai Mammen to Join FogPharma as Chairman
30 Mar 2023 //
BUSINESSWIRE
FogPharma hauls in $178M series D
21 Nov 2022 //
FIERCEBIOTECH
FogPharma Announces $178 Million Series D Financing to Advance Pipeline
21 Nov 2022 //
BUSINESSWIRE
FogPharma Selects Clinical Development Candidate Directly Targeting ?-Catenin
09 Mar 2022 //
BUSINESSWIRE
FogPharma Expands Executive Leadership Team
22 Nov 2021 //
BUSINESSWIRE
Copyright © 2024 LePro PharmaCompass OPC Private Limited, All rights reserved.